Dilon Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Dilon Technologies's estimated annual revenue is currently $17.8M per year.
- Dilon Technologies's estimated revenue per employee is $251,000
Employee Data
- Dilon Technologies has 71 Employees.
- Dilon Technologies grew their employee count by 42% last year.
Dilon Technologies's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | VP Engineering and Operations | Reveal Email/Phone |
4 | VP Quality | Reveal Email/Phone |
5 | Chief Commercial Officer US | Reveal Email/Phone |
6 | Education Director | Reveal Email/Phone |
7 | Director Finance And Human Resources | Reveal Email/Phone |
8 | Director R&D | Reveal Email/Phone |
9 | Quality Director | Reveal Email/Phone |
10 | Director US Surgical Sales | Reveal Email/Phone |
Dilon Technologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7M | 28 | 4% | N/A | N/A |
#2 | $19.8M | 79 | 4% | N/A | N/A |
#3 | $31.9M | 127 | 3% | N/A | N/A |
#4 | $53M | 211 | 2% | N/A | N/A |
#5 | $21.8M | 87 | -18% | N/A | N/A |
#6 | $353.7M | 1409 | 9% | N/A | N/A |
#7 | $7.8M | 31 | 15% | N/A | N/A |
#8 | $8.3M | 33 | 6% | N/A | N/A |
#9 | $22.6M | 90 | 29% | N/A | N/A |
#10 | $28.4M | 113 | -16% | $85.1M | N/A |
What Is Dilon Technologies?
SUMMARY Dilon Technologies will deliver clinically useful imaging and intraoperative systems appropriate for early disease diagnosis and surgical applications. The company operates a quality system that complies with all applicable regulations, standards and guidelines to deliver reliable technologies and products. DIAGNOSTIC IMAGING: Dilon's cornerstone product, the Dilon Molecular Breast Imaging System, is a high-resolution, compact camera, and is available as a single or dual head camera. The Dilon cameras have been optimized to perform Molecular Breast Imaging (MBI/BSGI) procedure that aids in early detection of breast cancer. The MBI procedure and its accessory for MBI guided breast biopsy has proven to detect cancers missed by Mammography and Ultrasound, while leading to fewer benign biopsies than MRI. Dilon is the exclusive North American distributor of GE's Discovery NM750b dual head MBI system. The Discovery NM 750b MBI system uses revolutionary and leading-edge, solid-state Cadmium Zinc Telluride (CZT) detectors to improve diagnostic accuracy in all types of patients. SURGICAL IMAGING: The Dilon Navigator® Gamma Probe is one of the most widely used gamma probes for cancer surgery in the marketplace. The Dilon Navigator 2.0 combines the reliability and features of its predecessor, the Navigator GPS, with state-of-the-art wireless probe technology in a new, sleek design. Lightweight and compact, this system is the ultimate in portability. The Navigator system provides the best gamma probe value in the market. AIRWAY IMAGING: The CoPilot VL® is an innovative and affordable video laryngoscope designed to make intubation and airway management quick and easy no matter where it is needed. Our patented Bougie Port system solves the issue of getting the endotracheal tube “around the corner†and into the trachea. The CoPilot VL® was designed to be the new standard of care for airway management. Every patient. Every time.
keywords:N/AN/A
Total Funding
71
Number of Employees
$17.8M
Revenue (est)
42%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Dilon Technologies News
BayCare, Dilon Technologies, GE Healthcare, Hologic, Philips Healthcare, Siemens Healthcare, SonoCine. This comprehensive Mammography Equipment Market...
Dilon Technologies Fujifilm Holdings Corporation, Gamma Medica General Electric Company, Hologic Koning Corporation, Koninklijke Philips...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.3M | 72 | -4% | N/A |
#2 | $16.1M | 73 | 0% | N/A |
#3 | $11.6M | 77 | 0% | N/A |
#4 | $23.5M | 81 | 5% | N/A |
#5 | $12.2M | 84 | -1% | N/A |